Black Garlic

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: immunity heart inflammation

Research Overview

Research on black garlic (BG; including aged black garlic, ABG) has focused most heavily on (i) processing/chemistry and resulting compositional changes, (ii) antioxidant capacity and related phytochemicals, and (iii) preclinical (in vitro and animal) evaluations of broad health-related effects. Multiple studies characterize BG as a heat-/humidity-aged or “fermented” garlic product with major physicochemical shifts during aging (e.g., decreasing pH, increasing reducing sugars and acidity, darkening via Maillard-type reactions) and increases in measured total polyphenols/flavonoids and antioxidant assay readouts (DPPH, ABTS, FRAP, reducing power), with at least one controlled aging study suggesting antioxidant metrics peak around ~21 days under specific conditions (70 °C, 90% RH). Chemical profiling work has also identified key aroma-active compounds (e.g., acetic acid, Furaneol, diallyl di-/trisulfides, allyl methyl trisulfide), reflecting substantial transformation of sulfur chemistry during processing. A parallel line of work emphasizes S-allyl cysteine (SAC) as a prominent bioactive in BG, with reviews compiling evidence that SAC concentrations can increase markedly in processed garlic relative to fresh garlic and that processing variables (heat, enzymatic treatment, freezing, fermentation, ultrasound, high hydrostatic pressure) influence SAC formation.

The strongest evidence supported by these abstracts is that BG differs materially from raw garlic in both composition and sensory properties (reduced pungency/odor; sweeter/sour profile) and that BG preparations consistently show high antioxidant potential in chemical assays and antioxidant-enriched fractions. Evidence for specific clinical benefits is comparatively less direct in the provided set: many claimed effects (anti-inflammatory, cardioprotective, anti-diabetic, etc.) are described as supported by extensive in vitro/in vivo studies, but comparative reviews note ABG may have lower activity than raw garlic for several endpoints (anti-inflammatory, anti-coagulation, immunomodulatory, anti-allergic). Importantly, one human bioavailability study using breath allyl methyl sulfide as a biomarker of allicin exposure reported very low “allicin bioavailability/bioequivalence” for black garlic (~5%) relative to homogenized raw garlic, indicating BG is unlikely to replicate raw-garlic allicin exposure and suggesting its biological effects—if present—may be mediated by other constituents (e.g., SAC, phenolics) rather than allicin.

Key gaps include a need for more well-controlled human studies (randomized trials with standardized BG preparations and dosing) that link specific BG constituents (notably SAC and transformed sulfur compounds) to clinically meaningful endpoints and validated biomarkers. Additional research is also needed to harmonize manufacturing/aging conditions with reproducible chemical profiles (since antioxidant measures and SAC levels vary with processing), to clarify mechanisms beyond generic “antioxidant” activity, and to directly compare BG with raw garlic and other garlic products using comparable outcome measures. Finally, the low allicin bioequivalence observed for BG highlights the importance of distinguishing BG’s effects from allicin-driven effects of raw garlic and of establishing which BG-derived metabolites are bioavailable and biologically active in humans.

1. What conditions has Black Garlic been studied for?

  • Cardiovascular risk factors (especially blood pressure) in people with moderate hypercholesterolemia (LDL-C ≥115 mg/dL), using a standardized aged black garlic (ABG) extract.

  • Colistin-induced nephrotoxicity (kidney injury from the antibiotic colistin): ABG extract is included among compounds studied for prevention/attenuation (mostly animal studies; one clinical trial in the overall review, not necessarily for ABG specifically).

  • Antioxidant-related outcomes (antioxidant activity assays and antioxidant component changes during aging/processing), including studies mapping polyphenols/flavonoids and antioxidant fractions.

  • Inflammation, coagulation, immune/allergic outcomes, metabolic outcomes: a review describes in vitro/in vivo evidence for ABG across many areas (anti-inflammatory, anti-cancer, anti-obesity, anti-diabetic, anti-allergic, cardioprotective, hepatoprotective, neuroprotective), and also notes some effects are lower than raw garlic.

  • Bioavailability of “allicin-related” activity: one study measured allicin bioavailability/bioequivalence (ABB) via breath allyl methyl sulfide after consuming different garlic foods; black garlic was included.

  • Immunomodulation (in vitro): polysaccharides from fresh vs black garlic were compared for chemical characteristics and immunomodulatory effects in vitro.

2. Does it work in treating those conditions? Summarize the evidence.

  • Blood pressure / cardiovascular risk: One randomized, crossover, double-blind, placebo-controlled trial in 67 hypercholesterolemic individuals tested 250 mg/day ABG extract standardized to 1.25 mg S-allyl-L-cysteine (SAC) for 6 weeks (with 3-week washout). ABG reduced diastolic blood pressure versus placebo by −5.85 mm Hg (95% CI −10.5 to −1.3), with the effect noted particularly in men with DBP > 75 mm Hg. This supports a modest BP-lowering effect in that population and product/dose.

  • Colistin-induced nephrotoxicity: A review of 30 articles (29 animal studies, 1 clinical trial overall) lists aged black garlic extract among compounds showing beneficial effects in most published works for preventing/attenuating colistin kidney toxicity. However, the abstract does not provide ABG-specific human outcomes; the evidence base appears primarily preclinical.

  • Antioxidant effects: Multiple processing/chemistry studies show black garlic develops higher measured antioxidant components and activity during aging. For example, under 70 °C and 90% RH, total polyphenols/flavonoids increased significantly up to day 21, and antioxidant activity (DPPH, ABTS, FRAP, reducing power) was highest at day 21. These are laboratory assays and do not by themselves prove clinical benefit.

  • Allicin-related activity compared with raw garlic: In a human bioavailability study using breath allyl methyl sulfide as a proxy for allicin exposure, black garlic showed 5% ABB relative to homogenized raw garlic (100% ABB). This suggests black garlic provides very low allicin-equivalent exposure compared with raw garlic, so any benefits are likely mediated by other compounds (e.g., SAC, polyphenols) rather than allicin.

  • Other claimed therapeutic areas (e.g., anti-cancer, anti-diabetic, anti-obesity, hepatoprotective, neuroprotective): A review states extensive in vitro and in vivo studies demonstrate these functions, but the abstract does not provide specific trial results or effect sizes. Overall, the strongest direct human evidence in the provided abstracts is for diastolic blood pressure reduction with a standardized ABG extract.

3. What health benefits does it have?

  • Potential blood pressure benefit: In a controlled human trial, a standardized ABG extract (1.25 mg SAC/day) lowered diastolic blood pressure over 6 weeks in moderate hypercholesterolemia, especially in men with higher baseline DBP.

  • Antioxidant capacity increases with aging/processing: During black garlic aging, polyphenols and flavonoids increase and antioxidant assay performance peaks (reported at day 21 under one set of conditions). Fractionation work also identified fractions (F3/F4) with higher phenolic content and stronger radical scavenging activity than others.

  • Higher S-allyl cysteine (SAC) content than fresh garlic: A review reports SAC in fresh garlic ranges from 19.0–1736.3 μg/g, while processed garlic including black garlic can increase up to 8021.2 μg/g. SAC is described as having antioxidant, anti-apoptotic, anti-inflammatory, anti-obesity, cardioprotective, neuroprotective, and hepatoprotective activities (largely based on preclinical evidence in the abstract).

  • Improved palatability vs raw garlic: A review notes aged black garlic has a sweet/sour taste and no strong odor, which may improve adherence compared with raw garlic. A fermentation study (with Wickerhamomyces anomalus) further reduced garlicky/pungent volatiles and bitterness (though with reduced antioxidant activities).

  • Potential immunomodulatory activity (in vitro): Polysaccharides from black garlic differ in molecular weight and monosaccharide composition versus fresh garlic, and were investigated for immunomodulatory effects in vitro (the abstract indicates differences but does not provide outcome magnitudes).

4. Does it have any downsides or side effects?

  • Lower allicin-equivalent exposure than raw garlic: Black garlic showed 5% allicin bioavailability/bioequivalence relative to raw garlic in a human breath-metabolite study. If a person is specifically seeking allicin-mediated effects, black garlic may be a poor substitute.

  • May be less potent than raw garlic for some immune/inflammation-related effects: A review states ABG shows lower anti-inflammatory, anti-coagulation, immunomodulatory, and anti-allergic effects compared to raw garlic (suggesting trade-offs with processing/aging).

  • Processing-dependent variability: Aging conditions change the chemical profile and may shift benefits. For example, one study found rapid heating/cooling retained ~1.7× higher SAC than gradual heating/cooling by the end of aging, while gradual heating/cooling produced higher polyphenols/fructose earlier. This implies product-to-product variability and that results from one standardized extract may not generalize to all black garlic foods/supplements.

  • Fermentation for flavor may reduce antioxidant activity: Yeast fermentation improved flavor (reduced garlicky odor and bitterness) but reduced antioxidant activities in black garlic juice in the cited study.

  • Adverse effects: The provided abstracts do not give specific rates or types of adverse events in humans for black garlic/ABG. One review states it covers adverse effects and limitations, but details are not included in the abstract, so side-effect conclusions cannot be quantified from the provided text.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not report pharmacogenomic analyses (e.g., outcomes stratified by genotype, gene–supplement interactions, or variant-specific safety signals) for black garlic or its key compounds (such as SAC). Therefore, based on these abstracts alone, no evidence-based claims can be made that black garlic is specifically beneficial or harmful for particular genetic variants.

References

  1. Allicin Bioavailability and Bioequivalence from Garlic Supplements and Garlic Foods.
    Larry D Lawson, Scott M Hunsaker (2018) - Nutrients
  2. Anti-Cancer and Anti-Inflammatory Properties of Black Garlic.
    Agnieszka Ewa Stępień, Julia Trojniak, Jacek Tabarkiewicz (2024) - International journal of molecular sciences
  3. Characterization of Key Aroma-Active Compounds in Black Garlic by Sensory-Directed Flavor Analysis.
    Ping Yang, Huanlu Song, Lijin Wang, Hao Jing (2019) - Journal of agricultural and food chemistry
  4. Black Garlic and Its Bioactive Compounds on Human Health Diseases: A Review.
    Tanvir Ahmed, Chin-Kun Wang (2021) - Molecules (Basel, Switzerland)
  5. The nutritional value, bioactive availability and functional properties of garlic and its related products during processing.
    Piyachat Sunanta, Vassilis Kontogiorgos, Tanachai Pankasemsuk, Kittisak Jantanasakulwong, Pornchai Rachtanapun, Phisit Seesuriyachan, Sarana Rose Sommano (2023) - Frontiers in nutrition
  6. S-Allyl cysteine in garlic (Allium sativum): Formation, biofunction, and resistance to food processing for value-added product development.
    Bara Yudhistira, Fuangfah Punthi, Jer-An Lin, Andi Syahrullah Sulaimana, Chao-Kai Chang, Chang-Wei Hsieh (2022) - Comprehensive reviews in food science and food safety
  7. Physicochemical Properties, Biological Activity, Health Benefits, and General Limitations of Aged Black Garlic: A Review.
    Ji Hyeon Ryu, Dawon Kang (2017) - Molecules (Basel, Switzerland)
  8. Physicochemical and antioxidant properties of black garlic.
    Il Sook Choi, Han Sam Cha, Young Soon Lee (2014) - Molecules (Basel, Switzerland)
  9. Pharmacological agents for the prevention of colistin-induced nephrotoxicity.
    Mahtabalsadat Mirjalili, Ehsan Mirzaei, Afsaneh Vazin (2022) - European journal of medical research
  10. Composition analysis and antioxidant properties of black garlic extract.
    Xiaoming Lu, Ningyang Li, Xuguang Qiao, Zhichang Qiu, Pengli Liu (2017) - Journal of food and drug analysis
  11. Effects of an Optimized Aged Garlic Extract on Cardiovascular Disease Risk Factors in Moderate Hypercholesterolemic Subjects: A Randomized, Crossover, Double-Blind, Sustainedand Controlled Study.
    Rosa M Valls, Judit Companys, Lorena Calderón-Pérez, Patricia Salamanca, Laura Pla-Pagà, Berner Andrée Sandoval-Ramírez, Antonio Bueno, Jose Puzo, Anna Crescenti, Josep M Del Bas, Antoni Caimari, Aurora Salamanca, Alberto E Espinel, Anna Pedret, Lluís Arola, Rosa Solà (2022) - Nutrients
  12. Widely targeted metabolomics and flavoromics reveal the effect of Wickerhamomyces anomalus fermentation on the volatile and nonvolatile metabolites of black garlic juice.
    Yan-Bing Huang, Fan-Bing Meng, Chuan-Xian Gong, Yun Deng, Yun-Cheng Li, Li-Shi Jiang, Yu Zhong (2024) - Food chemistry
  13. Effect of Temperature Conditions on the Physicochemical Quality of Aged Black Garlic.
    Jung-Hye Shin, Min-Jung Kang, Bo Hyun Lee, Dawon Kang (2024) - Foods (Basel, Switzerland)
  14. Comparison of Immunomodulatory Effects of Fresh Garlic and Black Garlic Polysaccharides on RAW 264.7 Macrophages.
    Min Li, Yi-Xi Yan, Qing-Tao Yu, Yong Deng, Ding-Tao Wu, Ying Wang, Ya-Zhong Ge, Shao-Ping Li, Jing Zhao (2017) - Journal of food science
  15. Black garlic exhibited hepatoprotective effect against monosodium glutamate-induced hepatotoxicity in animal model.
    Nora Maulina, Indra Zachreini, Gholib Gholib, Abdulhadi Suwandi, Muslim Akmal (2024) - Narra J
  16. Changes in Garlic Quality during Fermentation under Different Conditions.
    Aurelija Paulauskienė, Šarūnas Kulbokas, Egidijus Zvicevičius, Živilė Tarasevičienė (2024) - Foods (Basel, Switzerland)
  17. Determination of d- and l-Amino Acids in Garlic Foodstuffs by Liquid Chromatography-Tandem Mass Spectrometry.
    Mayu Onozato, Haruna Nakanoue, Tatsuya Sakamoto, Maho Umino, Takeshi Fukushima (2023) - Molecules (Basel, Switzerland)
  18. Improving endothelial health with food-derived H
    Federica Geddo, Giulia Querio, Alberto Asteggiano, Susanna Antoniotti, Alessandra Porcu, Andrea Occhipinti, Claudio Medana, Maria Pia Gallo (2023) - Food & function
  19. Antioxidant and Antiproliferative Activities of Several Garlic Forms.
    Zeinab Farhat, Tyler Scheving, Diana S Aga, Pamela A Hershberger, Jo L Freudenheim, Rachael Hageman Blair, Manoj J Mammen, Lina Mu (2023) - Nutrients
  20. Biochemical Composition, Antioxidant Activity and Antiproliferative Effects of Different Processed Garlic Products.
    Jingyang Lu, Nannan Li, Shuqin Li, Wei Liu, Mingyue Li, Min Zhang, Haixia Chen (2023) - Molecules (Basel, Switzerland)


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!